| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/27/2004 | WO2004044588A1 Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4) |
| 05/27/2004 | WO2004044587A2 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5) |
| 05/27/2004 | WO2004044586A1 Nanotube-based electronic detection of biological molecules |
| 05/27/2004 | WO2004044573A1 Transistor-based biosensors having gate electrodes coated with receptor molecules |
| 05/27/2004 | WO2004044570A1 Method of detecting hybridization |
| 05/27/2004 | WO2004044556A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | WO2004044555A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | WO2004044554A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | WO2004044549A2 Universal tag assay |
| 05/27/2004 | WO2004044247A2 One step real-time rt pcr kits for the universal detection of organisms in industrial products |
| 05/27/2004 | WO2004044246A2 Methods and compositions for detecting telomerase activity |
| 05/27/2004 | WO2004044245A1 Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation |
| 05/27/2004 | WO2004044244A1 Method of detecting human serotonin 5-ht4 receptor gene type in nucleic acid sample |
| 05/27/2004 | WO2004044243A1 Method of amplifying nucleic acid and apparatus tehrefor |
| 05/27/2004 | WO2004044242A1 Polymorphism assay |
| 05/27/2004 | WO2004044240A2 Method for conducting the parallel identification of different nucleic acids |
| 05/27/2004 | WO2004044239A1 Improved methods for generating multiple rna copies |
| 05/27/2004 | WO2004044238A1 Agents and methods for detecting human adenoviruses |
| 05/27/2004 | WO2004044237A1 Method of identifying and assessing dna euchromatin for detecting disease |
| 05/27/2004 | WO2004044236A1 Status determination |
| 05/27/2004 | WO2004044235A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) |
| 05/27/2004 | WO2004044234A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) |
| 05/27/2004 | WO2004044233A1 Phosphoamidase assay |
| 05/27/2004 | WO2004044232A1 Microparticle-based methods and systems and applications thereof |
| 05/27/2004 | WO2004044230A1 A methodology of estimating the conformation of a protein by proteolysis |
| 05/27/2004 | WO2004044229A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 05/27/2004 | WO2004044228A2 A continuous-read assay for the detection of de novo hcv rna polymerase activity |
| 05/27/2004 | WO2004044225A2 Methods for identifying dna copy number changes |
| 05/27/2004 | WO2004044221A2 High throughput automatic nucleic acid isolation and quantitation methods |
| 05/27/2004 | WO2004044218A2 Methods and materials for examining pathways associated with glioblastoma progression |
| 05/27/2004 | WO2004044209A1 A method of detection |
| 05/27/2004 | WO2004044203A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/27/2004 | WO2004044201A1 Signaling proteins participating in immunopotentiation by virus-origin double-stranded rna and endotoxin and genes thereof |
| 05/27/2004 | WO2004044193A1 Modified sarcosine oxidase, process for producing the same and reagent composition using the same |
| 05/27/2004 | WO2004044187A1 Rapid detection of bacterial spores |
| 05/27/2004 | WO2004044178A2 Methods and compositions for diagnosing dysplasia |
| 05/27/2004 | WO2004044177A2 Expression profiling based on histocultures |
| 05/27/2004 | WO2004044175A2 Fluorescence guided cell capture |
| 05/27/2004 | WO2004044171A2 Waveguide system for detection of fluorescently labeled nucleic acid sequences |
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044156A2 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/27/2004 | WO2004044154A2 Methods of identifying antineoplastic agents |
| 05/27/2004 | WO2004044148A2 Methods for the identification of trehalose-6-phosphate synthase as antibiotics |
| 05/27/2004 | WO2004044141A2 Conjugated oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044140A2 2’-substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004044139A2 Modified oligonucleotides for use in rna interference |
| 05/27/2004 | WO2004044137A2 Modified oligomeric compounds and compositions for use in gene modulation |
| 05/27/2004 | WO2004044136A2 Compositions comprising alternating 2’-modified nucleosides for use in gene modulation |
| 05/27/2004 | WO2004044135A2 Structural motifs and oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044133A2 Modified oligonucleotides for use in rna interference |
| 05/27/2004 | WO2004044132A2 Modified oligonucleotides for use in rna interference |
| 05/27/2004 | WO2004044131A2 Cross-linked oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044130A2 Microbial enzymes having multiple improved characteristics |
| 05/27/2004 | WO2004044128A2 An associative analysis of gene expression array data |
| 05/27/2004 | WO2004044122A2 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 05/27/2004 | WO2004044011A2 Combinatorial libraries of monomer domains |
| 05/27/2004 | WO2004043991A2 Assay for tissue factor and factor viia |
| 05/27/2004 | WO2004043988A2 Ptprk immunogenic peptide |
| 05/27/2004 | WO2004043979A2 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/27/2004 | WO2004043978A2 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004043977A2 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004043976A2 Mkk7gamma1 nucleic acids and polypeptides |
| 05/27/2004 | WO2004043407A2 Methods and products for treating staphylococcal infections |
| 05/27/2004 | WO2004043395A2 Methods and compositions for treating neurological disorders |
| 05/27/2004 | WO2004043387A2 Compositions and methods for cancer diagnosis and therapy |
| 05/27/2004 | WO2004043386A2 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | WO2004043371A2 Methods and compositions for modulating p53 transcription factor |
| 05/27/2004 | WO2004043370A2 Methods and compositions for modulating activator protein 1 |
| 05/27/2004 | WO2004043332A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | WO2004043238A2 Biomarkers for intra-amniotic inflammation |
| 05/27/2004 | WO2004043236A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | WO2004043232A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004043230A2 A method of screening for disorders of glucose metabolism |
| 05/27/2004 | WO2004043227A2 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae |
| 05/27/2004 | WO2004035835A3 Method for quantitative end-point pcr |
| 05/27/2004 | WO2004035808A3 Method for detecting viral inactivating agents |
| 05/27/2004 | WO2004031239A3 Metastasis inducing compounds |
| 05/27/2004 | WO2004024949A3 Method of rapid detection of mutations and nucleotide polymorphisms using chemometrics |
| 05/27/2004 | WO2004018626A3 Abasic site endonuclease assay |
| 05/27/2004 | WO2004016727A9 Determination and/or control of reactor environmental conditions |
| 05/27/2004 | WO2004010537B1 Flexible biochip |
| 05/27/2004 | WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 05/27/2004 | WO2004008147A3 Diagnosis and prevention of cancer cell invasion |
| 05/27/2004 | WO2004007762A3 Genes associated with schizophrenia, adhd and bipolar disorders |
| 05/27/2004 | WO2004003229A3 Disease risk estimating method using sequence polymorphisms in a specific region of chromosome 19 |
| 05/27/2004 | WO2004001655A8 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 05/27/2004 | WO2003102239A3 Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands |
| 05/27/2004 | WO2003094725A8 Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance |
| 05/27/2004 | WO2003089663A3 Methods for measuring enzyme activity |
| 05/27/2004 | WO2003087390A9 Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003076899A9 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 05/27/2004 | WO2003075833A3 Screening method for orthopoxvirus antivirals |
| 05/27/2004 | WO2003064448A3 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 05/27/2004 | WO2003061589A3 Methods for treating diseases or conditions with peptide constructs |
| 05/27/2004 | WO2003054550A3 Uses of an endothelial cell receptor |
| 05/27/2004 | WO2003054229A3 Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility |
| 05/27/2004 | WO2003045310A8 Digital assay |
| 05/27/2004 | WO2003045229A3 Methods and compositions for treating cancer |